基本情報
- 所属
- 自治医科大学 分子病態治療研究センター 領域融合治療研究部 / さいたま医療センター血液科 教授
- J-GLOBAL ID
- 201501000612691971
- researchmap会員ID
- B000247677
研究分野
1経歴
3-
2023年11月 - 現在
-
2015年4月 - 現在
-
2023年4月 - 2023年10月
論文
257-
The Journal of antimicrobial chemotherapy 61(2) 411-6 2008年2月 査読有りOBJECTIVES: Although Aspergillus galactomannan (GM) antigen detection is widely applied in the diagnosis of invasive aspergillosis (IA), false-positive reactions with fungus-derived antibiotics, other fungal genera or the passage of dietary GM through injured mucosa are a matter of concern. The aim of this study was to investigate the cumulative incidence and risk factors for false-positive GM antigenaemia. PATIENTS AND METHODS: The records of 157 adult allogeneic haematopoietic stem cell transplantation (HSCT) recipients were retrospectively analysed. Episodes of positive GM antigenaemia, defined as two consecutive GM results with an optical density index above 0.6, were classified into true, false and inconclusive GM antigenaemia by reviewing the clinical course. RESULTS: Twenty-five patients developed proven or probable IA with a 1 year cumulative incidence of 12.9%, whereas 50 experienced positive GM antigenaemia with an incidence of 32.2%. Among the total 58 positive episodes of the 50 patients, 29 were considered false-positive. The positive predictive value (PPV) was lower during the first 100 days than beyond 100 days after HSCT (37.5% versus 58.8%). Gastrointestinal chronic graft-versus-host disease (GVHD) was identified as the only independent significant factor for the increased incidence of false-positive GM antigenaemia (PPV 0% versus 66.7%, P = 0.02). CONCLUSIONS: GM antigen results must be considered cautiously in conjunction with other diagnostic procedures including computed tomography scans, especially during the first 100 days after HSCT and in patients with gastrointestinal chronic GVHD.
-
[Rinsho ketsueki] The Japanese journal of clinical hematology 48(8) 618-23 2007年8月 査読有りTwenty-three patients with acute myelogenous leukemia (AML) have received autologous hematopoietic stem cell transplantation (autoHSCT) in our institute from 1997 to 2005. Among them, 3 patients relapsed, and the other 4 patients (17%) showed cytogenetic abnormalities after the autoHSCT. In these 4 patients with AML1/MTG8 or CBFbeta/MYH11 AML, RT-PCR findings using bone marrow cells were all negative when a cytogenetic abnormality was detected. Myelodysplasia was not detected in the bone marrow and no abnormal findings were seen in the peripheral blood. Cytogenetic abnormalities were detected 12-48 months after AutoHSCT, which disappeared in three patients and decreased in the remaining one patient with a median follow up time of 51 months (30-72 months) after their detection. We present our finding together with a review of the literature on post-autoHSCT cytogenetic abnormalities not related to relapse or secondary leukemia/myelodysplastic syndrome.
-
[Rinsho ketsueki] The Japanese journal of clinical hematology 48(5) 351-352 2007年5月 査読有り
-
[Rinsho ketsueki] The Japanese journal of clinical hematology 47(12) 1533-8 2006年12月 査読有りSuperior sagittal sinus thrombosis (SSST) has been reported to be caused by coagulopathy following oral contraceptive therapy, DIC, infection around the sinus, compression from a tumor, infiltration of tumor, and an inherited deficiency of proteins C and S, but SSST associated with hematological malignancies and L-asparaginase (L-Asp) therapy is rare. We report a case of an adult patient with acute lymphoblastic leukemia (ALL) who developed SSST during the remission induction therapy. A 25-year-old man was admitted with left facial nerve palsy and, following bone marrow aspiration and lumbar puncture, he was diagnosed as having T-ALL with CNS involvement. He received a 1-AdVP regimen as remission induction therapy and intrathecal administration of methotrexate and cytarabine. On day 29, he had a generalized convulsion and SSST was demonstrated by imaging tests. Lymphoid malignancy (ALL in particular), the use of L-Asp, CNS involvement, and intrathecal chemotherapy might be risk factors for the occurrence SSST. When a patient with those factors develops any neurological symptoms, we should pay attention to the occurrence of SSST, as well as stroke or CNS involvement, though SSST is rare.
-
INTERNAL MEDICINE 44(3) 256-260 2005年3月 査読有りA 15-year-old Japanese man was referred for evaluation of heart failure. Conventional heart failure therapy had little effect, and severe left ventricular dysfunction as well as elevated erythrocyte sedimentation rate persisted. Magnetic resonance angiography showed aortic dilatation with wall thickening characteristic of Takayasu's arteritis. An endomyocardial biopsy specimen revealed infiltration of natural killer cells and gamma delta T lymphocytes, which play major roles in vascular injury of Takayasu's arteritis. Prednisolone administration provided great benefits to cardiac function. These findings suggest that autoimmune cytotoxic mechanisms similar to those in arterial tissue may contribute to cardiac impairment in Takayasu's arteritis.
-
琉球医学会誌 = Ryukyu Medical Journal 17(1) 57-60 1997年 査読有りAn autopsy case of T-cell lymphoma complicated with hemophagocytic syndrome (HPS) is reported. A 60-year-old woman presenting with fever and jaundice was transferred to our hospital. On admission, she showed bicytopenia, severe liver dysfunction and coagulopathy. She subsequently developed pancytopenia. At first, she was suspected of having aplastic anemia. Methylpredonisolone pulse therapy was therefore initiated, and the leukopenia improved. But she later developed leukopenia again, and died of septic shock. At autopsy, proliferation of histiocytes with hemophagocytosis was observed in the reticuloendothelial system. Moreover, T-cell lymphoma was observed. Hence diagnosis of T-cell lymphoma with HPS was made pathologically.
MISC
93-
臨床血液 64(4) 250-254 2023年4月34歳男性。KMT2A-MLLT1陽性急性骨髄性白血病の第1寛解期で,busulfan/高用量cyclophosphamideを前処置としてHLA適合の妹より同種末梢血幹細胞移植を施行した。Day14に生着し以降は寛解を維持した。重篤な移植片対宿主病も認めなかったが,経口cyclosporin(CsA)10mg/dayまで減量した移植後6ヶ月の時点で間質性肺炎を発症した。間質性肺炎に対して投与したprednisolone(PSL)の効果は一時的で,間質性肺炎は急速に増悪した。追加精査にて抗MDA5抗体陽性が判明したためcyclophosphamide+PSL+CsAによる3剤併用療法を開始して奏効が得られた。しかし,後遺症の呼吸不全で人工呼吸器管理を要したため,弟と妹より生体肺移植を施行した。3剤併用療法と生体肺移植により呼吸状態の改善を得た抗MDA5抗体陽性急速進行性間質性肺疾患の症例を経験したため,ここに報告する。(著者抄録)
共同研究・競争的資金等の研究課題
5-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2021年4月 - 2024年3月
-
日本学術振興会 科学研究費助成事業 2018年4月 - 2021年3月
-
日本学術振興会 科学研究費助成事業 2016年4月 - 2018年3月
-
日本学術振興会 科学研究費助成事業 2014年4月 - 2017年3月